Converting Enzyme Inhibition With an Orally Active Compound in Hypertensive Man

Hypertension - United States
doi 10.1161/01.hyp.1.1.39
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)